Gambro sales up 16% in nine months
This article was originally published in Clinica
Gambro's nine-month sales rose 16% to SKr 8,032 million ($1,210 million), when adjusted for exchange rate effects, and 9% when adjusted for acquisitions. The Swedish company reported operating earnings of SKr 1,079 million, down 3% from the previous year, or an increase of 10% when adjusted for currency effects and amortisation of goodwill. A provision of SKr 275 million has been allocated for a restructuring programme.